Andreas G. Bader

Biochemistry, Genetics and Molecular Biology · Life Sciences

33h-index11.9kcitations116works0.82yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(47), CAR-T cell therapy research(38), Circular RNAs in diseases(21), Monoclonal and Polyclonal Antibodies Research(18), RNA Interference and Gene Delivery(17)

Publications116 total

Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell function
Scientific Reports·2025· 1 citedOpen Access
Supplementary Figure 9 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 6 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Figure 5 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 5 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Figure 6 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 11 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Data from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 10 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 7 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 2 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 1 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Figure 4 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Figure 1 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 8 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Figure 3 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Materials from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Tables from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Figure 2 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
Supplementary Figure 3 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
2025Open Access
page 1 of 6Next →

Frequent Co-authors

Kevin Kelnar(14), Peter K. Vogt(13), Heidi J. Peltier(9), Jay Stoudemire(8), Sohye Kang(7), David Brown(7), Jasgit C. Sachdev(6), Mitesh J. Borad(6), Andrew Brenner(5), Stephen M. Smith(5), Sinil Kim(5), David S. Hong(5), Jane Zhao(5), Lubna Patrawala(4), Jason F. Wiggins(4), Yoon‐Koo Kang(4), Ho Yeong Lim(4), Muhammad Shaalan Beg(4), María Angélica Cortez(4), David R. Valdecanas(4)